Weight counseling in pediatric hidradenitis suppurativa patients

Barbara Reichert1, Esteban Fernandez Faith2, Katya Harfmann2

  • 1Oakview Dermatology, Springfield, Ohio.

Pediatric Dermatology
|March 4, 2020
PubMed

Insights

Few pediatric hidradenitis suppurativa patients receive weight counseling, despite obesity worsening the condition. Primary care providers initiate most referrals, highlighting a gap in specialist involvement for managing this chronic disease.

Area of Science:

  • Pediatric Dermatology
  • Chronic Inflammatory Diseases
  • Public Health

Background:

  • Hidradenitis suppurativa (HS) is a chronic, debilitating skin condition that can affect children and adolescents.
  • Overweight and obesity are recognized as factors that exacerbate HS severity.
  • Weight management counseling is often insufficient for pediatric HS patients.

Purpose of the Study:

  • To determine the rate of weight counseling provided to pediatric HS patients.
  • To identify the medical specialties most frequently involved in managing these patients.
  • To assess referral patterns to weight management services.

Main Methods:

  • Retrospective review of medical charts for pediatric HS patients (2011-2018).
  • Collection of demographic data, anthropometric measurements (height, weight, BMI), and BMI percentiles.
  • Analysis of departmental visits and referrals to a specialized weight management center.

Main Results:

  • 535 pediatric HS patients were analyzed; 79.6% were female, with a mean age of 14.5 years at diagnosis.
  • Overweight (11.6%) and obese (54.2%) patients constituted the majority.
  • Only 32.1% of overweight/obese patients received a weight management referral, primarily from Primary Care (not Dermatology).

Conclusions:

  • There is a critical need to enhance awareness and education regarding weight management and nutrition for pediatric HS patients.
  • Dermatologists and other specialists should increase their role in providing weight counseling.
  • Further research is required to evaluate the effectiveness of weight interventions on HS disease severity.
Abstract

Related Concept Videos

Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
233
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
154
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
278
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
274
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
198
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
565